-+ 0.00%
-+ 0.00%
-+ 0.00%

Medley, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Simply Wall St·11/16/2026 00:03:45
Listen to the news

Last week, you might have seen that Medley, Inc. (TSE:4480) released its quarterly result to the market. The early response was not positive, with shares down 8.1% to JP¥2,108 in the past week. It looks to have been a decent result overall - while revenue fell marginally short of analyst estimates at JP¥11b, statutory earnings beat expectations by a notable 19%, coming in at JP¥9.36 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

earnings-and-revenue-growth
TSE:4480 Earnings and Revenue Growth November 16th 2026

Following the latest results, Medley's four analysts are now forecasting revenues of JP¥54.7b in 2027. This would be a major 28% improvement in revenue compared to the last 12 months. Per-share earnings are expected to jump 110% to JP¥114. Before this earnings report, the analysts had been forecasting revenues of JP¥55.9b and earnings per share (EPS) of JP¥113 in 2027. The consensus seems maybe a little more pessimistic, trimming their revenue forecasts after the latest results even though there was no change to its EPS estimates.

Check out our latest analysis for Medley

The average price target was steady at JP¥3,358even though revenue estimates declined; likely suggesting the analysts place a higher value on earnings. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Medley, with the most bullish analyst valuing it at JP¥4,400 and the most bearish at JP¥2,890 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Medley shareholders.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Medley's past performance and to peers in the same industry. We would highlight that Medley's revenue growth is expected to slow, with the forecast 22% annualised growth rate until the end of 2027 being well below the historical 29% p.a. growth over the last five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 11% per year. Even after the forecast slowdown in growth, it seems obvious that Medley is also expected to grow faster than the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also downgraded Medley's revenue estimates, but industry data suggests that it is expected to grow faster than the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. The consensus price target held steady at JP¥3,358, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Medley going out to 2028, and you can see them free on our platform here.

Plus, you should also learn about the 2 warning signs we've spotted with Medley .